[go: up one dir, main page]

PL1747008T3 - Surowe ekstrakty z Andrographis paniculata - Google Patents

Surowe ekstrakty z Andrographis paniculata

Info

Publication number
PL1747008T3
PL1747008T3 PL05742174T PL05742174T PL1747008T3 PL 1747008 T3 PL1747008 T3 PL 1747008T3 PL 05742174 T PL05742174 T PL 05742174T PL 05742174 T PL05742174 T PL 05742174T PL 1747008 T3 PL1747008 T3 PL 1747008T3
Authority
PL
Poland
Prior art keywords
crude extracts
andrographis paniculata
paniculata
andrographis
crude
Prior art date
Application number
PL05742174T
Other languages
English (en)
Inventor
Xiaoqiang Yan
Tao Wang
Zhiming Ma
Weihan Zhang
Jifen Duan
Yu Cai
Original Assignee
Nutrition Science Partners Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition Science Partners Ltd filed Critical Nutrition Science Partners Ltd
Publication of PL1747008T3 publication Critical patent/PL1747008T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
PL05742174T 2004-04-28 2005-04-26 Surowe ekstrakty z Andrographis paniculata PL1747008T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56647704P 2004-04-28 2004-04-28
EP05742174.5A EP1747008B1 (en) 2004-04-28 2005-04-26 Crude extracts from andrographis paniculata
PCT/US2005/014288 WO2005104722A2 (en) 2004-04-28 2005-04-26 Crude extracts from andrographis paniculata

Publications (1)

Publication Number Publication Date
PL1747008T3 true PL1747008T3 (pl) 2015-10-30

Family

ID=35242143

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05742174T PL1747008T3 (pl) 2004-04-28 2005-04-26 Surowe ekstrakty z Andrographis paniculata

Country Status (14)

Country Link
US (3) US7341748B2 (pl)
EP (1) EP1747008B1 (pl)
JP (1) JP5221128B2 (pl)
KR (3) KR101536892B1 (pl)
AU (1) AU2005237550B2 (pl)
CA (1) CA2564637C (pl)
DK (1) DK1747008T3 (pl)
ES (1) ES2534594T3 (pl)
HU (1) HUE025117T2 (pl)
PL (1) PL1747008T3 (pl)
PT (1) PT1747008E (pl)
RU (1) RU2383353C2 (pl)
TW (1) TWI373340B (pl)
WO (1) WO2005104722A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2006135836A (ru) * 2004-03-11 2008-04-20 Хатчисон Медифарма Лтд. (Cn) АНДРОГРАФОЛИД И АНАЛОГИ В КАЧЕСТВЕ ИНГИБИТОРОВ ЭКСПРЕССИИ TNFα И IL-1β
PL1747008T3 (pl) 2004-04-28 2015-10-30 Nutrition Science Partners Ltd Surowe ekstrakty z Andrographis paniculata
JP2007176934A (ja) * 2005-11-30 2007-07-12 Kose Corp 血小板活性化因子アセチルヒドロラーゼ機能調整剤
US20070202164A1 (en) * 2006-02-28 2007-08-30 Hutchison Medipharma Enterprises Limited Andrographis Extract Formulations
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
US20090117209A1 (en) * 2007-11-02 2009-05-07 Hutchison Medipharma Enterprises Limited Andrographis paniculata extract
SG174892A1 (en) * 2009-03-24 2011-11-28 Univ Singapore Use of andrographolide compounds for treating inflammation and airway disorders
MD480Z5 (ro) * 2011-07-07 2012-09-30 Эльвира АНДОН Metodă de tratament al colitei ulceroase nespecifice acute
CN102702147B (zh) * 2012-06-18 2016-06-08 辽宁利锋科技开发有限公司 穿心莲内酯类似物及其治疗的应用
CN103145660B (zh) * 2013-03-25 2014-09-17 成都天台山制药有限公司 穿心莲内酯及其制备方法
CN103145661B (zh) * 2013-03-25 2014-06-18 成都天台山制药有限公司 穿心莲内酯的新晶型
CN103223028A (zh) * 2013-03-27 2013-07-31 张宗升 中药提取物
CN103766901A (zh) * 2014-01-08 2014-05-07 浙江大学 一种穿心莲丙素在制备减肥食品或药品中的应用
JP6386761B2 (ja) * 2014-03-19 2018-09-05 花王株式会社 インボルクリン発現抑制剤
MY176459A (en) * 2016-05-23 2020-08-10 Univ Putra Malaysia Extract of andrographis paniculata for cognitive enhancement
WO2018081959A1 (en) 2016-11-02 2018-05-11 Nutrition Science Partners Limited Extracts of andrographis paniculata, methods for preparation and use thereof
CN107349253A (zh) * 2017-06-23 2017-11-17 苏州凌科特新材料有限公司 无刺激医用消毒液及其制备方法
WO2022058422A1 (en) * 2020-09-17 2022-03-24 Dsm Ip Assets B.V. Use of andrographis paniculata extract to protect against air pollution related diseases
WO2024092327A1 (pt) * 2022-10-31 2024-05-10 Mey, Angelica Machado Composição para obtenção de bioativo natural para terapias oncológicas
KR102713383B1 (ko) * 2023-09-04 2024-10-04 김현주 인간을 제외한 동물의 면역력 증진을 위한 조성물

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1012941B (zh) 1989-07-29 1991-06-26 郭如明 穿心莲碱水法新工艺
AU4376396A (en) * 1994-12-06 1996-06-26 Paracelsian, Inc. Use of andrographolide compounds to treat or prevent pathogenicity of diseases
US20030059471A1 (en) 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
ATE383875T1 (de) * 1998-03-17 2008-02-15 Chugai Pharmaceutical Co Ltd Prophylaktische oder therapeutische mittel gegen entzündliche erkrankungen des verdauungstraktes enthaltend antagonistische il-6 rezeptor antikörper
JP2000034233A (ja) * 1998-07-15 2000-02-02 Sumitomo Forestry Co Ltd 一酸化窒素産生抑制剤
JP2001058969A (ja) * 1999-08-20 2001-03-06 Nettairin Saisei Gijutsu Kenkyu Kumiai 一酸化窒素産生抑制剤
DE60119534T2 (de) 2000-07-28 2007-05-10 Immupharm Aps Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
US6629835B2 (en) 2000-08-01 2003-10-07 Metaproteomics, Llc Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2
US6358526B1 (en) 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
US7270835B2 (en) 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20030101076A1 (en) 2001-10-02 2003-05-29 Zaleski John R. System for supporting clinical decision making through the modeling of acquired patient medical information
US6753017B2 (en) 2001-11-07 2004-06-22 Jrs Pharma Lp Process for preparing dry extracts
JP2003171301A (ja) 2001-11-09 2003-06-20 Mahidol Univ 歯周炎治療における補助剤としてのカルメグゲル
JP4669920B2 (ja) 2002-08-21 2011-04-13 沖縄県 血糖上昇抑制且つ血圧上昇抑制作用を有する機能性素材
CN1488376A (zh) 2003-05-09 2004-04-14 江西诚志信丰药业有限责任公司 一种治疗肠道疾病及鼻窦炎的药物胶囊及其制备方法
CN1626076B (zh) 2003-12-11 2010-10-06 天津天士力制药股份有限公司 一种穿心莲内酯滴丸及其制备方法
KR101065608B1 (ko) 2003-12-29 2011-09-19 주식회사 엘지생활건강 안드로그라폴라이드 또는 안드로그라폴라이드를유효성분으로 함유하는 천심련 추출물을 포함하는가려움증 억제 또는 완화 조성물
RU2006135836A (ru) 2004-03-11 2008-04-20 Хатчисон Медифарма Лтд. (Cn) АНДРОГРАФОЛИД И АНАЛОГИ В КАЧЕСТВЕ ИНГИБИТОРОВ ЭКСПРЕССИИ TNFα И IL-1β
PL1747008T3 (pl) 2004-04-28 2015-10-30 Nutrition Science Partners Ltd Surowe ekstrakty z Andrographis paniculata
EP1758554A1 (en) 2004-06-12 2007-03-07 Passion For Life Healthcare Limited Soluble strip for oral or topical adminstration
CN1628764A (zh) 2004-08-19 2005-06-22 贵阳云岩西创药物科技开发有限公司 穿心莲制剂及其制备方法
US20070202164A1 (en) 2006-02-28 2007-08-30 Hutchison Medipharma Enterprises Limited Andrographis Extract Formulations
US20090117209A1 (en) 2007-11-02 2009-05-07 Hutchison Medipharma Enterprises Limited Andrographis paniculata extract

Also Published As

Publication number Publication date
ES2534594T3 (es) 2015-04-24
WO2005104722A2 (en) 2005-11-10
WO2005104722A3 (en) 2006-03-02
RU2383353C2 (ru) 2010-03-10
PT1747008E (pt) 2015-03-31
JP5221128B2 (ja) 2013-06-26
TWI373340B (en) 2012-10-01
KR20130012979A (ko) 2013-02-05
EP1747008A4 (en) 2009-04-22
US7341748B2 (en) 2008-03-11
CA2564637A1 (en) 2005-11-10
KR101534844B1 (ko) 2015-07-07
DK1747008T3 (en) 2015-03-30
KR20070033982A (ko) 2007-03-27
TW200538144A (en) 2005-12-01
KR101531116B1 (ko) 2015-06-23
CA2564637C (en) 2013-09-10
USRE43423E1 (en) 2012-05-29
EP1747008B1 (en) 2015-01-14
JP2007535542A (ja) 2007-12-06
AU2005237550A1 (en) 2005-11-10
RU2006141834A (ru) 2008-06-10
KR101536892B1 (ko) 2015-07-14
HUE025117T2 (en) 2016-02-29
AU2005237550B2 (en) 2010-09-23
KR20150047645A (ko) 2015-05-04
USRE42718E1 (en) 2011-09-20
EP1747008A2 (en) 2007-01-31
US20060246156A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
PT1747008E (pt) Extrato em bruto de andrographis paniculata
EP2217254A4 (en) EXTRACT FROM ANDROGRAPHIS PANICULATA
GB2436211B (en) Capacitor assembly
GB0911796D0 (en) An extract
EP1755970A4 (en) REUSABLE BOTTLE PAD
GB2442403B (en) Single-transformer digital isolation barrier
GB2450845B (en) Corona ground element
EP1790239A4 (en) GNETUM EXTRACT
TWI369213B (en) Therapeutic gastrodia extracts
GB0609670D0 (en) Detonation interrupter
EP1996165A4 (en) PREPARATIONS BASED ON ANDROGRAPHIS EXTRACT
PL1784181T3 (pl) Zahamowanie czynnika wzrostu śródbłonka naczyniowego
EP1956563A4 (en) coin dispensing
SG114746A1 (en) Stabilized hydroxypivalaldehyde
GB0409846D0 (en) Tea extracts
GB0501052D0 (en) Curb set and match
GB0611566D0 (en) Adjustable tamper assembly
GB0403099D0 (en) Extracts
GB0516930D0 (en) Extracts
GB201003229D0 (en) Single-transformer digital isolation barrier
GB0414148D0 (en) Herbal ciggerette
EG25404A (en) Temporary bridge.
PL115342U1 (en) Sleeve stopper
AU2007906004A0 (en) Plantago coronopus stops internal hemorrinages and flash and removes stones from the kitneys
GB0417751D0 (en) Stopper rod